A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV)

Clinical trial NCT07663838 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07663838
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Randomized Open-label Safety Tolerability Pharmacokinetics Bacterial Vaginosis

Start date: 2026-06-15
Primary completion: 2027-01-05
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.